ROGER CRYSTAL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROGER CRYSTAL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROGER CRYSTAL. ROGER CRYSTAL is Chief Executive Officer in OPIANT PHARMACEUTICALS, INC. ($OPNT).
Latest Insider Trading Transactions of ROGER CRYSTAL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | A | 12.15 | 31,250 | 379,688 | 31,250 | |
Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Grant | A | 0.00 | 15,650 | 0 | 41,541 | 25.9 K to 41.5 K (+60.45 %) |
Jan 27 2021 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Grant | A | 0.00 | 3,766 | 0 | 25,891 | 22.1 K to 25.9 K (+17.02 %) |
Jan 09 2020 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | A | 13.60 | 27,250 | 370,600 | 27,250 | |
Jan 09 2020 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Grant | A | 0.00 | 13,650 | 0 | 22,125 | 8.5 K to 22.1 K (+161.06 %) |
Apr 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 21,472 | 155,672 | 375,000 | |
Apr 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 12.10 | 12,772 | 154,541 | 8,475 | 21.2 K to 8.5 K (-60.11 %) |
Apr 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 11.98 | 16,001 | 191,692 | 21,247 | 37.2 K to 21.2 K (-42.96 %) |
Apr 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 21,472 | 155,672 | 37,248 | 15.8 K to 37.2 K (+136.11 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 22,557 | 163,538 | 396,472 | |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 5,149 | 37,330 | 419,029 | |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 822 | 5,960 | 424,178 | |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 11.93 | 16,836 | 200,853 | 15,776 | 32.6 K to 15.8 K (-51.63 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 22,557 | 163,538 | 32,612 | 10.1 K to 32.6 K (+224.34 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 12.24 | 3,791 | 46,402 | 10,055 | 13.8 K to 10.1 K (-27.38 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 12.48 | 600 | 7,488 | 13,846 | 14.4 K to 13.8 K (-4.15 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 5,149 | 37,330 | 14,446 | 9.3 K to 14.4 K (+55.38 %) |
Apr 04 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 822 | 5,960 | 9,297 | 8.5 K to 9.3 K (+9.70 %) |
Jan 17 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | A | 14.62 | 13,200 | 192,984 | 13,200 | |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 6.00 | 25,000 | 150,000 | 50,000 | |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 8,641 | 62,647 | 425,000 | |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 16,359 | 118,603 | 433,641 | |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 13.27 | 11,407 | 151,371 | 8,475 | 19.9 K to 8.5 K (-57.37 %) |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 13.28 | 26,759 | 355,360 | 19,882 | 46.6 K to 19.9 K (-57.37 %) |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 6.00 | 25,000 | 150,000 | 46,641 | 21.6 K to 46.6 K (+115.52 %) |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 8,641 | 62,647 | 21,641 | 13 K to 21.6 K (+66.47 %) |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 13.54 | 11,834 | 160,232 | 13,000 | 24.8 K to 13 K (-47.65 %) |
Jan 08 2019 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 16,359 | 118,603 | 24,834 | 8.5 K to 24.8 K (+193.03 %) |
Oct 10 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 17.04 | 6,941 | 118,275 | 8,475 | 15.4 K to 8.5 K (-45.02 %) |
Oct 10 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 17.33 | 3,059 | 53,012 | 15,416 | 18.5 K to 15.4 K (-16.56 %) |
Oct 10 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 18.14 | 847 | 15,365 | 18,475 | 19.3 K to 18.5 K (-4.38 %) |
Oct 04 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Option Exercise | M | 7.25 | 50,000 | 362,500 | 450,000 | |
Oct 04 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 18.43 | 4,006 | 73,831 | 19,322 | 23.3 K to 19.3 K (-17.17 %) |
Oct 04 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 19.23 | 4,300 | 82,689 | 23,328 | 27.6 K to 23.3 K (-15.56 %) |
Oct 04 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Sell | S | 17.51 | 10,144 | 177,621 | 27,628 | 37.8 K to 27.6 K (-26.86 %) |
Oct 04 2018 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | M | 7.25 | 29,297 | 212,403 | 37,772 | 8.5 K to 37.8 K (+345.69 %) |
Jan 19 2017 | OPNT | OPIANT PHARMACEUTI ... | CRYSTAL ROGER | Chief Executive Off ... | Buy | P | 6.99 | 3,475 | 24,290 | 8,475 | 5 K to 8.5 K (+69.50 %) |
Page: 1